TY - JOUR
T1 - An Evaluation of Hepatitis E Virus Molecular Typing Methods
AU - HEV Sequencing Study Group
AU - Baylis, Sally A.
AU - Adlhoch, Cornelia
AU - Childs, Liam
AU - Suin, Vanessa
AU - Lamoral, Sophie
AU - Nasheri, Neda
AU - Harlow, Jennifer
AU - Rešetnjak, Irina
AU - Abravanel, Florence
AU - Lhomme, Sebastien
AU - Izopet, Jacques
AU - Pavio, Nicole
AU - Pellerin, Marie
AU - Eiden, Martin
AU - Boettcher, Birke
AU - Kaiser, Marco
AU - Schilling-Loeffler, Katja
AU - Johne, Reimar
AU - Schwarz, Tatjana
AU - Corman, Victor M.
AU - Wenzel, Jürgen J.
AU - Klein, Jasmin
AU - Bennett, Charlene
AU - DeGascun, Cillian
AU - Dean, Jonathan
AU - Ciccaglione, Anna Rita
AU - Villano, Umbertina
AU - Bruni, Roberto
AU - Di Bartolo, Ilaria
AU - De Sabato, Luca
AU - La Rosa, Giuseppina
AU - Ferraro, Giusy Bonanno
AU - Mancini, Pamela
AU - Suffredini, Elisabetta
AU - Garbuglia, Anna Rosa
AU - Boxman, Ingeborg
AU - Dirks, René
AU - Zwartkruis-Nahuis, Ans
AU - Hogema, Boris
AU - de Sousa, Rita
AU - Velebit, Branko
AU - Avellón, Ana
AU - Sánchez, Gloria
AU - Cuevas-Ferrando, Enric
AU - Norder, Heléne
AU - Bachofen, Claudia
AU - Vonlanthen, Isabelle
AU - Kubacki, Jakub
AU - Lacher, David
AU - Mammel, Mark
N1 - Publisher Copyright:
© American Association for Clinical Chemistry 2021.
PY - 2022
Y1 - 2022
N2 - BACKGROUND: Hepatitis E virus (HEV) is a major cause of acute viral hepatitis. Better understanding of HEV subtypes involved in hepatitis E infections is essential. Investigation of sources and routes of transmission and the identification of potential clusters/outbreaks rely upon molecular typing of viral strains. A study was carried out to evaluate the ability of laboratories to undertake molecular typing with genotype and subtype determination. METHODS: A blinded panel of 11 different Orthohepevirus A strains was distributed to 28 laboratories performing HEV sequence analysis. Laboratories used their routine HEV sequencing and genotyping methods. RESULTS: Results were returned by 25 laboratories. Overall, 93% samples were assigned to the correct genotype and 81% were assigned to the correct subtype. Fragments amplified for typing ranged in size and the sequencing assays targeted both the structural and non-structural protein-coding regions. There was good agreement between the reported sequences where methods targeted overlapping fragments. In some cases, incorrect genotypes/subtypes were reported, including those not contained in the panel, and in one case, a genotype was reported for a blinded control sample containing Zika virus; collectively these data indicate contamination problems. CONCLUSIONS: In general, identification of genotypes was good; however, in a small number of cases, there was a failure to generate sequences from some of the samples. There was generally broad agreement between the use of online typing tools such as the one provided by HEVnet and curated lists of published HEV reference sequences; however, going forward harmonization between these resources is essential.
AB - BACKGROUND: Hepatitis E virus (HEV) is a major cause of acute viral hepatitis. Better understanding of HEV subtypes involved in hepatitis E infections is essential. Investigation of sources and routes of transmission and the identification of potential clusters/outbreaks rely upon molecular typing of viral strains. A study was carried out to evaluate the ability of laboratories to undertake molecular typing with genotype and subtype determination. METHODS: A blinded panel of 11 different Orthohepevirus A strains was distributed to 28 laboratories performing HEV sequence analysis. Laboratories used their routine HEV sequencing and genotyping methods. RESULTS: Results were returned by 25 laboratories. Overall, 93% samples were assigned to the correct genotype and 81% were assigned to the correct subtype. Fragments amplified for typing ranged in size and the sequencing assays targeted both the structural and non-structural protein-coding regions. There was good agreement between the reported sequences where methods targeted overlapping fragments. In some cases, incorrect genotypes/subtypes were reported, including those not contained in the panel, and in one case, a genotype was reported for a blinded control sample containing Zika virus; collectively these data indicate contamination problems. CONCLUSIONS: In general, identification of genotypes was good; however, in a small number of cases, there was a failure to generate sequences from some of the samples. There was generally broad agreement between the use of online typing tools such as the one provided by HEVnet and curated lists of published HEV reference sequences; however, going forward harmonization between these resources is essential.
UR - https://www.scopus.com/pages/publications/85123036891
U2 - 10.1093/clinchem/hvab186
DO - 10.1093/clinchem/hvab186
M3 - Article
C2 - 34969109
AN - SCOPUS:85123036891
SN - 0009-9147
VL - 68
SP - 181
EP - 191
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 1
ER -